Edinburgh Molecular Imaging Appoints Bernhard Sixt as new Chief Executive Officer

8 Nov 2018 | Corporate, Press Releases

Seasoned CEO with 30 years’ experience in the healthcare industry  Edinburgh, United Kingdom – 8 November 2018 – Edinburgh Molecular Imaging (EM Imaging), the optical molecular imaging company, today announces the appointment of Dr Bernhard Sixt as Chief...

Edinburgh Molecular Imaging Ltd Appoints New Chairman

29 Oct 2018 | Corporate, Press Releases

EDINBURGH, Scotland, October 29, 2018 – Roy Davis appointed as Non-Executive Chairman – Current Chair John Jeans to continue as Non-Executive Director Edinburgh Molecular Imaging Ltd (EM Imaging), the clinical phase biotechnology company focused on...

Edinburgh Molecular Imaging announce Bowel Cancer UK and Beating Bowel Cancer as charity partner

21 Mar 2018 | Collaborations

Bowel Cancer UK and Beating Bowel Cancer announced as Edinburgh Molecular (EM) Imaging’s Charity partner. EM Imaging, based in Edinburgh, is partnering with Bowel Cancer UK and Beating Bowel Cancer to raise funds for the charity and increase awareness of Scotland’s...

Edinburgh Molecular Imaging Commences Phase II European Cancer Trial

20 Sep 2017 | EMI-137

Novel Compound with Potential for Early Detection and to Guide Treatment of Colorectal Cancer Edinburgh, UK – 19 September 2017: Edinburgh Molecular Imaging (EM Imaging), the clinical phase biotechnology company focused on enabling image-guided therapy, announces it...

Edinburgh Molecular Imaging Supports BHF Grant

2 Jun 2017 | Collaborations

Edinburgh Molecular Imaging is proud to support the University of Edinburgh team.The researchers aim to create new chemicals – known as tracers – to illuminate these unstable plaques in patients. The tracers – which contain small amounts of radioactivity – are...